Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06333028 · ClinicalTrials.gov registry record
A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction
A clinical trial, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- 82
- Enrollment target
NCT06333028 is a clinical trial that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 82 participants.
The verdict
NCT06333028 has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- 82 participants
- Enrollment target
Study Summary
A Study to Evaluate the enVista® Aspire (EA) intraocular lens in Subjects Undergoing Cataract Extraction
Interventions
- DEVICE enVista Aspire EA IOLs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2024-05-30 |
| Est. Completion | 2025-03-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06333028
The ClinicalTrials.gov registry entry for NCT06333028 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which enVista Aspire EA IOLs is the first listed.
NCT06333028 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06333028 about?
NCT06333028 is a clinical study titled "A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction". A Study to Evaluate the enVista® Aspire (EA) intraocular lens in Subjects Undergoing Cataract Extraction
What is the current status of trial NCT06333028?
This trial is currently completed. The enrollment target is 82 participants. The study started on 2024-05-30. Estimated completion is 2025-03-13.
What interventions are being tested in trial NCT06333028?
The interventions under investigation include: enVista Aspire EA IOLs (DEVICE).
Who is sponsoring clinical trial NCT06333028?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.